Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide Background Retatrutide (LY3437943) is the first GLP-1/GIP/GCG triple agonist to complete phase 2 trials, with phase 3 studies ongoing for obesity and/or T2D management
Colin Raymond Feb 7, 2025 4 min read Updated: Nov 4, 2025 In the world of weight management and metabolic health, GLP-1 (Glucagon-Like Peptide-1) has become a game-changer
Unlike traditional braces, KLOwen Braces are custom-made to fit your teeth and your treatment needs
Weekly Wegovy Injection Wegovy is an injectable semaglutide treatment generally administered once per week as prescribed
Studies of patients on chronic steroids report 5 to 10% body weight gain over 6 to 12 months
It feels different because of the way the body handles alcohol over time
US$ 25.65
US$ 24.86
US$ 22.87
US$ 28.45
